Evidence map›Paper›PMID 38732003›Full record

ArticleInternational journal of molecular sciences2024

Anna Och, Marta Kinga Lemieszek, Marek Cieśla, Dariusz Jedrejek, Aleksandra Kozłowska, Sylwia Pawelec, Renata Nowak

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna OchDepartment of Pharmaceutical Botany, Medical University of Lublin, 1 Chodźki St., 20-093 Lublin, Poland.
Marta Kinga LemieszekDepartment of Medical Biology, Institute of Rural Health, 20-090 Lublin, Poland.ORCID 0000-0001-9367-0684
Marek CieślaCollege of Medical Sciences, University of Rzeszow, 35-310 Rzeszow, Poland.
Dariusz JedrejekDepartment of Biochemistry and Crop Quality, Institute of Soil Science and Plant Cultivation-State Rsearch Institute, Czartoryskich 8 Street, 24-100 Puławy, Poland.
Aleksandra KozłowskaDepartment of Radiotherapy, Medical University of Lublin, 13 Radziwiłłowska St., 20-080 Lublin, Poland.
Sylwia PawelecDepartment of Biochemistry and Crop Quality, Institute of Soil Science and Plant Cultivation-State Rsearch Institute, Czartoryskich 8 Street, 24-100 Puławy, Poland.ORCID 0000-0002-9191-6836
Renata NowakDepartment of Pharmaceutical Botany, Medical University of Lublin, 1 Chodźki St., 20-093 Lublin, Poland.ORCID 0000-0003-4952-3147

Funding

Medical University of Lublin DS 46
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaApoptosisBerberisColonic NeoplasmsPlant ExtractsPlant RootsAntineoplastic Agents, PhytogenicCell Line, TumorHT29 CellsHumansAntineoplastic Agents, PhytogenicPlant Extractsanti-inflammatoryantioxidantsantiproliferativeBerberis vulgaris L.colon cancerHT-29inflammatory bowel diseaseLS180phytopharmacology

Identifiers

PMID38732003
PMCPMC11084310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.